Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? - Systematic review and meta-analysis

Thrombosis and Haemostasis

Volumn 101, Issue 5, 2009, Pages 813-817

  Pezzini, Alessandro ^a   Grassi, Mario ^b   Del Zotto, Elisabetta ^a,c   Giossi, Alessia ^a   Volonghi, Irene ^a   Costa, Paolo ^a   Grau, Armin ^d   Magoni, Mauro ^e   Padovani, Alessandro ^a   Lichy, Christoph ^f  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Medizinische Klinik C   (Germany)

^e Stroke Unit   (Italy)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Patent foramen ovale; Prothrombotic disorders; Stroke; Young

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTHROMBIN;

ARTICLE; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DISEASE ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MUTATION; PATENT FORAMEN OVALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SYSTEMATIC REVIEW;

BRAIN ISCHEMIA; FACTOR V; FORAMEN OVALE, PATENT; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION; ODDS RATIO; PROTHROMBIN; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOSIS;

EID: 66149163104     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-11-0747     Document Type: Article

References (13)

1. Thaler DA, Saver JL. Cryptogenic stroke and patent foramen ovale. Curr Opin Cardiol 2008; 23: 537-544.
2. Saver JL. Cryptogenic stroke in patients with patent foramen ovale. Curr Atheroscler Rep 2007; 9: 319-325. (Pubitemid 350089221)
3. Pezzini A, Del Zotto E, Magoni M, et al. Inherited thrombophilic disorders in young adults with ischaemic stroke and patent foramen ovale. Stroke 2003; 34: 28-33. (Pubitemid 36070795)
4. Lichy C, Reuner KH, Buggle F, et al. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischaemia. Cerebrovasc Dis 2003; 16: 83-87. (Pubitemid 36677001)
5. Belvis R, Santamaria A, Marti-Fabregas J, et al. Patent foramen ovale and prothrombotic markers in young stroke patients. Blood Coagul Fibrinolysis 2007; 18: 537-542. (Pubitemid 47344300)
6. Offelli P, Zanchetta M, Pedon L, et al. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 2007; 98: 906-907.
7. Karttunen V, Hiltunen L, Rasi V, et al. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003; 14: 261-268. (Pubitemid 36589148)
8. Botto N, Spadoni I, Giusti S, et al. Prothrombotic mutations as risk factors for cryptogenic ischaemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38: 2070-2073. (Pubitemid 47012269)
9. Silver MD, Dorsey GS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978; 102: 62-65. (Pubitemid 8297363)
10. Schneider B, Hanrath P, Vogel P, et al. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990; 16: 1000-1009. (Pubitemid 20353426)
11. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischaemic stroke of unknown cause. Stroke 2000; 31: 398-403. (Pubitemid 30078172)
12. Martinelli I, Battaglioli T, Razzari C, et al. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia. J Thromb Haemost 2007; 5: 98-101.
13. Egger M, Davey Smith G. Meta-analysis. Bias in location and selection of studies. Br Med J 1998; 316: 61-66.